If proven effective in humans, the vaccine could complement standard therapies for HPV-driven cancer, as well as inform the ...

The vaccine against human papillomavirus, or HPV, has reduced cervical cancer by nearly 90% in women vaccinated as ...

Every day almost 2,000 women around the world sit down opposite a doctor and are told they have cervical cancer.

Researchers suggest cancer-causing HPV strains might raise women's heart risks. Oct. 24, 2011— -- A virus responsible for the majority of cervical cancers might also raise a woman's risk of heart ...

Human papilloma virus (HPV) illustration. Now Stephen Akinfenwa, an internal medicine resident at the University of Connecticut School of Medicine and one of the lead authors of the analysis, says he ...

Women are four times more likely to die from heart disease and six times more likely to die from stroke if infected with a high-risk strain of human papillomavirus (HPV), a new study warns. HPV ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Women with ...

For HPV testing for detection of cervical intraepithelial neoplasia grade 2/3 or worse, minipad-collected menstrual blood shows comparable diagnostic accuracy.

The effectiveness and required dosage of HPV vaccines change depending on the age of the receiver, shares Dr Tanaya Narendra.

The findings will be published today (February 11) in Science Advances.

Testing menstrual blood for human papillomavirus (HPV) could be a "robust alternative or replacement" for current cervical ...

Nepal intensifies its Human Papillomavirus (HPV) vaccination drive targeting girls aged 10 to 19, ahead of the March 5 elections. The campaign aims to immunize over 400,000 girls against cervical ...